Goodman Advisory Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,755
Closed -$120K 157
2025
Q1
$120K Buy
+5,755
New +$109K 0.04% 86
2023
Q1
Sell
-3,243
Closed -$69K 161
2022
Q4
$69K Sell
3,243
-912,034
-100% -$18.9M 0.04% 69
2022
Q3
$18.6M Buy
915,277
+909,636
+16,125% +$18.1M 10.15% 3
2022
Q2
$123K Buy
+5,641
New +$114K 0.05% 59

Other funds holding BTAL

Goodman Advisory Group's BTAL Position: Q2 2025 in Review

Goodman Advisory Group sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2025, closing a stake of 5,755 shares — an estimated $120K sold.

Goodman Advisory Group first reported a position in BTAL in Q2 2022 and held it in 4 quarters. The position peaked at $18.6M in Q3 2022. 80 funds tracked by Wall St. Rank hold BTAL as of Q2 2025.

  • Goodman Advisory Group reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2025 after selling out during the quarter.
  • Goodman Advisory Group sold 5,755 AGF US Market Neutral Anti-Beta Fund shares in Q2 2025, an estimated $120K.
  • Goodman Advisory Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2022 and held it in 4 quarters.
  • Goodman Advisory Group's AGF US Market Neutral Anti-Beta Fund position peaked at $18.6M in Q3 2022.
  • 80 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2025.

Based on Goodman Advisory Group's 13F filing for Q2 2025, filed 18 Aug 2025.